Third Harmonic Bio Inc. (THRD) — Cash Flow-to-Debt Ratio
Third Harmonic Bio Inc. (THRD) has a Cash Flow-to-Debt Ratio of -1.87x as of March 2025, meaning its operating cash flow of $-13.48 Million could theoretically repay -2% of its total liabilities ($7.21 Million) in one year. Explore how efficiently does Third Harmonic Bio Inc. generate cash to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Third Harmonic Bio Inc. Cash Flow-to-Debt Ratio (2020–2024)
Historical debt coverage capacity for Third Harmonic Bio Inc. across 5 annual periods. Also explore THRD asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Third Harmonic Bio Inc. (2020–2024)
Year-by-year debt coverage analysis for Third Harmonic Bio Inc.. For market capitalisation and broader financial context, see Third Harmonic Bio Inc. stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.65x | $-34.50 Million | $9.46 Million | ▼ -54.1% |
| 2023 | -2.37x | $-20.43 Million | $8.63 Million | ▲ +34.9% |
| 2022 | -3.63x | $-34.92 Million | $9.61 Million | ▼ -3959.5% |
| 2021 | -0.09x | $-15.75 Million | $175.87 Million | ▲ +73.9% |
| 2020 | -0.34x | $-9.19 Million | $26.79 Million | — |